184 related articles for article (PubMed ID: 35471658)
1. Evaluating performance of existing computational models in predicting CD8+ T cell pathogenic epitopes and cancer neoantigens.
Buckley PR; Lee CH; Ma R; Woodhouse I; Woo J; Tsvetkov VO; Shcherbinin DS; Antanaviciute A; Shughay M; Rei M; Simmons A; Koohy H
Brief Bioinform; 2022 May; 23(3):. PubMed ID: 35471658
[TBL] [Abstract][Full Text] [Related]
2. A robust deep learning workflow to predict CD8 + T-cell epitopes.
Lee CH; Huh J; Buckley PR; Jang M; Pinho MP; Fernandes RA; Antanaviciute A; Simmons A; Koohy H
Genome Med; 2023 Sep; 15(1):70. PubMed ID: 37705109
[TBL] [Abstract][Full Text] [Related]
3. Isolation of T cell receptors targeting recurrent neoantigens in hematological malignancies.
Tubb VM; Schrikkema DS; Croft NP; Purcell AW; Linnemann C; Freriks MR; Chen F; Long HM; Lee SP; Bendle GM
J Immunother Cancer; 2018 Jul; 6(1):70. PubMed ID: 30001747
[TBL] [Abstract][Full Text] [Related]
4. Analyzing the effect of peptide-HLA-binding ability on the immunogenicity of potential CD8+ and CD4+ T cell epitopes in a large dataset.
Wang S; Li J; Chen X; Wang L; Liu W; Wu Y
Immunol Res; 2016 Aug; 64(4):908-18. PubMed ID: 27094547
[TBL] [Abstract][Full Text] [Related]
5. Personalized neoantigen viro-immunotherapy platform for triple-negative breast cancer.
Brito Baleeiro R; Liu P; Chard Dunmall LS; Di Gioia C; Nagano A; Cutmore L; Wang J; Chelala C; Nyambura LW; Walden P; Lemoine N; Wang Y
J Immunother Cancer; 2023 Aug; 11(8):. PubMed ID: 37586771
[TBL] [Abstract][Full Text] [Related]
6. Immunogenic T cell epitopes of SARS-CoV-2 are recognized by circulating memory and naïve CD8 T cells of unexposed individuals.
Quiros-Fernandez I; Poorebrahim M; Fakhr E; Cid-Arregui A
EBioMedicine; 2021 Oct; 72():103610. PubMed ID: 34627082
[TBL] [Abstract][Full Text] [Related]
7. Sequence-based prediction of SARS-CoV-2 vaccine targets using a mass spectrometry-based bioinformatics predictor identifies immunogenic T cell epitopes.
Poran A; Harjanto D; Malloy M; Arieta CM; Rothenberg DA; Lenkala D; van Buuren MM; Addona TA; Rooney MS; Srinivasan L; Gaynor RB
Genome Med; 2020 Aug; 12(1):70. PubMed ID: 32791978
[TBL] [Abstract][Full Text] [Related]
8. Mass spectrometric identification of immunogenic SARS-CoV-2 epitopes and cognate TCRs.
Pan K; Chiu Y; Huang E; Chen M; Wang J; Lai I; Singh S; Shaw RM; MacCoss MJ; Yee C
Proc Natl Acad Sci U S A; 2021 Nov; 118(46):. PubMed ID: 34725257
[TBL] [Abstract][Full Text] [Related]
9. NetMHCstab - predicting stability of peptide-MHC-I complexes; impacts for cytotoxic T lymphocyte epitope discovery.
Jørgensen KW; Rasmussen M; Buus S; Nielsen M
Immunology; 2014 Jan; 141(1):18-26. PubMed ID: 23927693
[TBL] [Abstract][Full Text] [Related]
10. Immunogenic self-peptides - the great unknowns in autoimmunity: Identifying T-cell epitopes driving the autoimmune response in autoimmune diseases.
Prinz JC
Front Immunol; 2022; 13():1097871. PubMed ID: 36700227
[TBL] [Abstract][Full Text] [Related]
11. Immune-based mutation classification enables neoantigen prioritization and immune feature discovery in cancer immunotherapy.
Bai P; Li Y; Zhou Q; Xia J; Wei PC; Deng H; Wu M; Chan SK; Kappler JW; Zhou Y; Tran E; Marrack P; Yin L
Oncoimmunology; 2021 Jan; 10(1):1868130. PubMed ID: 33537173
[TBL] [Abstract][Full Text] [Related]
12. Mutation position is an important determinant for predicting cancer neoantigens.
Capietto AH; Jhunjhunwala S; Pollock SB; Lupardus P; Wong J; Hänsch L; Cevallos J; Chestnut Y; Fernandez A; Lounsbury N; Nozawa T; Singh M; Fan Z; de la Cruz CC; Phung QT; Taraborrelli L; Haley B; Lill JR; Mellman I; Bourgon R; Delamarre L
J Exp Med; 2020 Apr; 217(4):. PubMed ID: 31940002
[TBL] [Abstract][Full Text] [Related]
13. Low HLA binding of diabetes-associated CD8+ T-cell epitopes is increased by post translational modifications.
Sidney J; Vela JL; Friedrich D; Kolla R; von Herrath M; Wesley JD; Sette A
BMC Immunol; 2018 Mar; 19(1):12. PubMed ID: 29562882
[TBL] [Abstract][Full Text] [Related]
14. TLimmuno2: predicting MHC class II antigen immunogenicity through transfer learning.
Wang G; Wu T; Ning W; Diao K; Sun X; Wang J; Wu C; Chen J; Xu D; Liu XS
Brief Bioinform; 2023 May; 24(3):. PubMed ID: 36960769
[TBL] [Abstract][Full Text] [Related]
15. A Systematic, Unbiased Mapping of CD8
Stryhn A; Kongsgaard M; Rasmussen M; Harndahl MN; Østerbye T; Bassi MR; Thybo S; Gabriel M; Hansen MB; Nielsen M; Christensen JP; Randrup Thomsen A; Buus S
Front Immunol; 2020; 11():1836. PubMed ID: 32983097
[TBL] [Abstract][Full Text] [Related]
16. Metadherin peptides containing CD4(+) and CD8(+) T cell epitopes as a therapeutic vaccine candidate against cancer.
Dhiman G; Lohia N; Jain S; Baranwal M
Microbiol Immunol; 2016 Sep; 60(9):646-52. PubMed ID: 27554419
[TBL] [Abstract][Full Text] [Related]
17. Prediction of neo-epitope immunogenicity reveals TCR recognition determinants and provides insight into immunoediting.
Schmidt J; Smith AR; Magnin M; Racle J; Devlin JR; Bobisse S; Cesbron J; Bonnet V; Carmona SJ; Huber F; Ciriello G; Speiser DE; Bassani-Sternberg M; Coukos G; Baker BM; Harari A; Gfeller D
Cell Rep Med; 2021 Feb; 2(2):100194. PubMed ID: 33665637
[TBL] [Abstract][Full Text] [Related]
18. IEPAPI: a method for immune epitope prediction by incorporating antigen presentation and immunogenicity.
Deng J; Zhou X; Zhang P; Cheng W; Liu M; Tian J
Brief Bioinform; 2023 Jul; 24(4):. PubMed ID: 37232386
[TBL] [Abstract][Full Text] [Related]
19. TCR contact residue hydrophobicity is a hallmark of immunogenic CD8+ T cell epitopes.
Chowell D; Krishna S; Becker PD; Cocita C; Shu J; Tan X; Greenberg PD; Klavinskis LS; Blattman JN; Anderson KS
Proc Natl Acad Sci U S A; 2015 Apr; 112(14):E1754-62. PubMed ID: 25831525
[TBL] [Abstract][Full Text] [Related]
20. Structure Based Prediction of Neoantigen Immunogenicity.
Riley TP; Keller GLJ; Smith AR; Davancaze LM; Arbuiso AG; Devlin JR; Baker BM
Front Immunol; 2019; 10():2047. PubMed ID: 31555277
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
